company background image
A323990 logo

Vaxcell-Bio Therapeutics KOSDAQ:A323990 Stock Report

Last Price

₩14.18k

Market Cap

₩326.0b

7D

-5.5%

1Y

-59.4%

Updated

04 Sep, 2024

Data

Company Financials

Vaxcell-Bio Therapeutics Co., Ltd.

KOSDAQ:A323990 Stock Report

Market Cap: ₩326.0b

A323990 Stock Overview

Develops and sells cancer immune cell therapy products in South Korea.

A323990 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Vaxcell-Bio Therapeutics Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vaxcell-Bio Therapeutics
Historical stock prices
Current Share Price₩14,180.00
52 Week High₩47,416.67
52 Week Low₩13,010.00
Beta3.6
11 Month Change3.73%
3 Month Change-16.78%
1 Year Change-59.44%
33 Year Change-77.81%
5 Year Changen/a
Change since IPO59.77%

Recent News & Updates

We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

Jul 29
We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

Apr 01
We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

Recent updates

We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

Jul 29
We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

Apr 01
We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

Shareholder Returns

A323990KR BiotechsKR Market
7D-5.5%-1.3%-1.0%
1Y-59.4%35.1%-0.1%

Return vs Industry: A323990 underperformed the KR Biotechs industry which returned 35.1% over the past year.

Return vs Market: A323990 underperformed the KR Market which returned -0.1% over the past year.

Price Volatility

Is A323990's price volatile compared to industry and market?
A323990 volatility
A323990 Average Weekly Movement7.0%
Biotechs Industry Average Movement9.3%
Market Average Movement6.5%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A323990's share price has been volatile over the past 3 months.

Volatility Over Time: A323990's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/an/awww.vaxcell-bio.com

Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.

Vaxcell-Bio Therapeutics Co., Ltd. Fundamentals Summary

How do Vaxcell-Bio Therapeutics's earnings and revenue compare to its market cap?
A323990 fundamental statistics
Market cap₩326.04b
Earnings (TTM)-₩10.43b
Revenue (TTM)₩69.60m

4,685x

P/S Ratio

-31.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A323990 income statement (TTM)
Revenue₩69.60m
Cost of Revenue₩35.33m
Gross Profit₩34.27m
Other Expenses₩10.47b
Earnings-₩10.43b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-453.72
Gross Margin49.24%
Net Profit Margin-14,989.18%
Debt/Equity Ratio0%

How did A323990 perform over the long term?

See historical performance and comparison